hematopoietic cell transplantation

  1. forestglip

    Trial Report REGENECYTE cord blood cell therapy in post-COVID syndrome: a phase IIa randomized, placebo-controlled trial, 2026, Huang et al

    REGENECYTE cord blood cell therapy in post-COVID syndrome: a phase IIa randomized, placebo-controlled trial [Line breaks added] Background Post-COVID syndrome affects a substantial proportion of individuals worldwide and imposes significant healthcare and economic burdens. Fatigue is one of...
  2. O

    Orthostatic intolerance syndromes after hematopoietic cell transplantation, 2021, Vecchié et al

    Orthostatic intolerance syndromes after hematopoietic cell transplantation: clinical characteristics and therapeutic interventions in a single-center experience Abstract Background Hematopoietic cell transplantation (HCT) is an established and potentially curative therapeutic option for...
Back
Top Bottom